Bilcare Limited (BOM:526853)
India
· Delayed Price · Currency is INR 61.01
-0.62 (-1.01%)
At close: Apr 28, 2026
Bilcare Revenue
Bilcare had revenue of 1.81B INR in the quarter ending December 31, 2025, a decrease of -8.48%. This brings the company's revenue in the last twelve months to 7.40B, down -6.82% year-over-year. In the fiscal year ending March 31, 2025, Bilcare had annual revenue of 7.88B with 5.47% growth.
Revenue (ttm)
7.40B
Revenue Growth
-6.82%
P/S Ratio
0.20
Revenue / Employee
94.86M
Employees
78
Market Cap
1.44B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 7.88B | 408.57M | 5.47% |
| Mar 31, 2024 | 7.47B | -2.34B | -23.88% |
| Mar 31, 2023 | 9.82B | 1.37B | 16.21% |
| Mar 31, 2022 | 8.45B | 2.22B | 35.65% |
| Mar 31, 2021 | 6.23B | -12.04B | -65.92% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Coral Laboratories | 875.55M |
| Lactose (India) | 1.45B |
| Astonea Labs | 1.17B |
| Bal Pharma | 3.09B |
| Parnax Lab | 2.28B |
| Concord Drugs | 512.41M |
| Aayush Wellness | 1.29B |
| Pharmaids Pharmaceuticals | 255.33M |